Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (not Envue Medical, Inc.) on April 3, 2017, covering the event date of March 31, 2017. The registrant is incorporated in Delaware with principal executive offices in Nesher, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
The material change reported is the departure of a director:
- Ira Greenstein submitted his resignation as a member of the Board of Directors.
- The resignation became effective immediately on March 31, 2017.
- Management stated the resignation was not in connection with any disagreement regarding the Company's operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Greenstein's departure.
- Confirm whether a replacement director has been appointed or if a vacancy remains.
- Review subsequent filings for any undisclosed disagreements or strategic shifts related to this departure.